Editorial: A call to recognize PCP.
D000476:Alkanesulfonates / Q000627:therapeutic use; D000578:Amidines / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D003906:Developing Countries; D004359:Drug Therapy, Combination; D006801:Humans; D007223:Infant; D008168:Lung / Q000473:pathology; D010647:Phenyl Ethers / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D011502:Protein-Energy Malnutrition / Q000150:complications; D011739:Pyrimethamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013424:Sulfanilamides / Q000031:analogs & derivatives / Q000627:therapeutic use; D013577:Syndrome
D000476:Alkanesulfonates; D000578:Amidines; D010647:Phenyl Ethers; D011743:Pyrimidines; D013424:Sulfanilamides; D013411:Sulfadiazine; D011739:Pyrimethamine